Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy (Q35108333)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy |
scientific article |
Statements
1 reference
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy (English)
1 reference
C R Garrett
1 reference
L L Siu
1 reference
A El-Khoueiry
1 reference
J Buter
1 reference
C M Rocha-Lima
1 reference
J Marshall
1 reference
P LoRusso
1 reference
P Major
1 reference
J Chemidlin
1 reference
O Mokliatchouk
1 reference
L Velasquez
1 reference
W Hayes
1 reference
D Feltquate
1 reference
S Syed
1 reference
S Ford
1 reference
G Kollia
1 reference
S Galbraith
1 reference
D S A Nuyten
1 reference
31 May 2011
1 reference
1 reference
105
1 reference
1
1 reference
44-52
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference